Drug Type Small molecule drug |
Synonyms Tosufloxacin, Tosufloxacin Tosilate, Tosufloxacin Tosylate + [13] |
Mechanism Bacterial DNA gyrase inhibitors, Topoisomerase IV inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (23 Jan 2006), |
Regulation- |
Molecular FormulaC19H15F3N4O3 |
InChIKeyWUWFMDMBOJLQIV-UHFFFAOYSA-N |
CAS Registry100490-36-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Tosufloxacin Tosilate Hydrate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Blepharitis | JP | 23 Jan 2006 | |
Corneal Ulcer | JP | 23 Jan 2006 | |
Dacryocystitis | JP | 23 Jan 2006 | |
Hordeolum | JP | 23 Jan 2006 |
Not Applicable | 8 | Tosufl oxacin tosilate (TFLX) | nogwxajwbw(vdmmvjvnfe) = eight cases of AKI that occurred after administration of TFLX and NSAIDs in children onmymnmknd (rgnxzsneau ) View more | Negative | 11 Nov 2014 |